Whilst researchers hunt for biomarkers to predict ketamine reaction, clinicians come across by themselves with a conundrum: Which patients need to start with IV ketamine, and which with Spravato? And how do the two compare head to head in true response to treatment? So Curiously plenty of, there was a https://josephv000qes7.smblogsites.com/profile